2-[4-(2H-1,3-benzodioxol-5-yl)-3-tert-butyl-1-(2-methylphenyl)-7-oxo-1,4,6,7-tetrahydro-8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-(butan-2-yl)acetamide
Chemical Structure Depiction of
2-[4-(2H-1,3-benzodioxol-5-yl)-3-tert-butyl-1-(2-methylphenyl)-7-oxo-1,4,6,7-tetrahydro-8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-(butan-2-yl)acetamide
2-[4-(2H-1,3-benzodioxol-5-yl)-3-tert-butyl-1-(2-methylphenyl)-7-oxo-1,4,6,7-tetrahydro-8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-(butan-2-yl)acetamide
Compound characteristics
Compound ID: | V020-3122 |
Compound Name: | 2-[4-(2H-1,3-benzodioxol-5-yl)-3-tert-butyl-1-(2-methylphenyl)-7-oxo-1,4,6,7-tetrahydro-8H-pyrazolo[3,4-e][1,4]thiazepin-8-yl]-N-(butan-2-yl)acetamide |
Molecular Weight: | 548.7 |
Molecular Formula: | C30 H36 N4 O4 S |
Smiles: | CCC(C)NC(CN1C(CSC(c2ccc3c(c2)OCO3)c2c(C(C)(C)C)nn(c3ccccc3C)c12)=O)=O |
Stereo: | MIXTURE OF STEREOISOMERS |
logP: | 5.9494 |
logD: | 5.9494 |
logSw: | -5.4821 |
Hydrogen bond acceptors count: | 8 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 71.295 |
InChI Key: | XSNNUTNCKRYCNP-UHFFFAOYSA-N |